SM
ACHN

Sabby Management’s Achillion Pharmaceuticals ACHN Stock Holding History

Sabby Management’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-992
Closed -$286K – 214
2017
Q4 		$286K Hold
992
– – 0.03% 115
2017
Q3 		$445K Sell
992
-258
-21% -$1.15K 0.03% 106
2017
Q2 		$574K Sell
1,250
-5,113
-80% -$20.6K 0.04% 131
2017
Q1 		$2.68M Sell
6,363
-3,724
-37% -$15.5K 0.14% 72
2016
Q4 		$4.17M Buy
10,087
+1,048
+12% +$5.57K 0.24% 61
2016
Q3 		$7.32M Buy
9,039
+5,212
+136% +$44.3K 0.27% 55
2016
Q2 		$2.98M Buy
3,827
+1,529
+67% +$13.1K 0.16% 79
2016
Q1 		$1.77M Sell
2,298
-3,580
-61% -$26.2K 0.09% 114
2015
Q4 		$6.34M Sell
5,878
-1,038
-15% -$9.44K 0.35% 50
2015
Q3 		$4.78M Hold
6,916
– – 0.2% 86
2015
Q2 		$6.13M Buy
6,916
+1,477
+27% +$14K 0.22% 84
2015
Q1 		$5.36M Buy
5,439
+2,720
+100% +$34K 0.22% 72
2014
Q4 		$3.33K Sell
2,719
-11,496
-81% -$140K 0.11% 91
2014
Q3 		$14.2K Sell
14,215
-1,772
-11% -$16.4K 0.54% 34
2014
Q2 		$12.1M Buy
15,987
+1,294
+9% +$5.16K 0.52% 35
2014
Q1 		$4.83M Sell
14,693
-7,886
-35% -$27.6K 0.27% 64
2013
Q4 		$7.5M Sell
22,579
-1,560
-6% -$4.53K 0.48% 42
2013
Q3 		$7.29M Buy
24,139
+16,659
+223% +$114K 0.47% 44
2013
Q2 		$6.12M Buy
+7,480
New +$57.1K 0.41% 56

Other funds holding ACHN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Sabby Management's ACHN Position: Q1 2018 in Review

Sabby Management sold out of Achillion Pharmaceuticals (ACHN) in Q1 2018, closing a stake of 16,705 shares — an estimated $48K sold.

Sabby Management first reported a position in ACHN in Q3 2013 and held it in 8 quarters. The position peaked at $1.5M in Q4 2013. 127 funds tracked by Wall St. Rank hold ACHN as of Q1 2018.

  • Sabby Management reported no remaining Achillion Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Sabby Management sold 16,705 Achillion Pharmaceuticals shares in Q1 2018, an estimated $48K.
  • Sabby Management first reported a position in Achillion Pharmaceuticals in Q3 2013 and held it in 8 quarters.
  • Sabby Management's Achillion Pharmaceuticals position peaked at $1.5M in Q4 2013.
  • 127 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2018.

Based on Sabby Management's 13F filing for Q1 2018, filed 15 May 2018.